These results are consistent with previous reports, demonstrating that TMP significantly decreases CXCR4 expression in human retinoblastoma SO-Rb50 cells, cerebral neurocytes and rat C6 glioma cells [15], [26], [30]. The gene discussed is CXCR4; the disease is central nervous system cancer.